Ana M. Rodriguez is with the Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston. Thuy Quynh N. Do is with the Department of Preventive Medicine and Population Health, University of Texas Medical Branch. Maria L. Jibaja-Weiss is with the Department of Pediatrics, Section of Hematology-Oncology, Dan L Duncan Comprehensive Cancer Center, Office of Outreach and Health Disparities, Baylor College of Medicine, Houston, TX. Lu Chen and Yong-Fang Kuo are with the Office of Biostatistics, Preventive Medicine and Population Health, University of Texas Medical Branch. Kathleen M. Schmeler is with the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston. Jane R. Montealegre is with the Baylor College of Medicine-Houston School of Health Professions, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine.
Am J Public Health. 2022 Sep;112(9):1269-1272. doi: 10.2105/AJPH.2022.306970. Epub 2022 Jul 21.
This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr-San Juan-Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (. 2022;112(9):1269-1272. https://doi.org/10.2105/AJPH.2022.306970).
这项准实验研究(以社区为基础、以医生为主导的人乳头瘤病毒[HPV]教育活动和学校为基础的疫苗接种计划)跟踪了 2016 年 8 月至 2021 年 3 月间得克萨斯州里奥格兰德河谷 Pharr-San Juan-Alamo 独立学区 8 所中学的 6481 名学生。我们描述了在 COVID-19 大流行期间经历的成功和挑战。HPV 疫苗接种的起始率和完成率分别在 2019 年 6 月至 2021 年 3 月期间增加了 1.29 倍和 1.47 倍。2020 年 3 月至 2021 年 3 月期间,通过 24 项以学校为基础的干预措施提供了 268 剂 HPV 疫苗。我们的项目继续取得成功,HPV 疫苗接种率不断提高,可能由 HPV 引起的癌症也在减少。(2022;112(9):1269-1272。https://doi.org/10.2105/AJPH.2022.306970)。